Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Journal Club
  • Published:

Antenatal Late Preterm Steroids (ALPS): are we ready to accept it?

Manuscript Citation:Gyamfi-Bannerman C, et al."Antenatal Betamethasone For Women At Risk For Late Preterm Delivery". N Engl J Med 2016; 374: 1311–1320.

Journal of Perinatology volume 37, pages 624–625 (2017)Cite this article

Subjects

Treatment/prevention.

(P) In women at risk for late-preterm delivery (34 to 37 weeks gestational age), does (I) intramuscular betamethasone given between 24 h and 7 days prior to delivery (C) compared with placebo (O) decrease the risk of neonatal morbidities including respiratory outcomes and neonatal intensive care unit (NICU) admission?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Razaz N, Skoll A, Fahey J, Allen VM, Joseph KS . Trends in optimal, suboptimal, and questionably appropriate receipt of antenatal corticosteroid prophylaxis. Obstet Gynecol 2015; 125 (2): 288–296.

    Article  Google Scholar 

  2. Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita ATN, Reddy UM, Saade GR et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016; 374 (14): 1311–1320.

    Article  CAS  Google Scholar 

  3. Asztalos EV, Murphy KE, Willan AR, Matthews SG, Ohlsson A, Saigal S et al. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr 2013; 167 (12): 1102–1110.

    PubMed  Google Scholar 

  4. Carson R, Monaghan-Nichols AP, DeFranco DB, Rudine AC . Effects of antenatal glucocorticoids on the developing brain. Steroids 2016; 114: 25–32.

    Article  Google Scholar 

  5. Crowther CA, Harding JE, Middleton PF, Andersen CC, Ashwood P, Robinson JS et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy Childbirth 2013; 13: 104.

    Article  CAS  Google Scholar 

  6. Kamath-Rayne BD, Rozance PJ, Goldenberg RL, Jobe AH . Antenatal corticosteroids beyond 34 weeks gestation: what do we do now? Am J Obstet Gynecol 2016; 215 (4):423–430.

    Article  CAS  Google Scholar 

  7. ACOG. Antenatal corticosteroid use for fetal maturation. Committee Opinion, Number 677, 2016..

Download references

Author information

Authors and Affiliations

  1. Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

    S Kamatkar & A Jobe

Authors
  1. S Kamatkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Jobe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Kamatkar.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kamatkar, S., Jobe, A. Antenatal Late Preterm Steroids (ALPS): are we ready to accept it?. J Perinatol 37, 624–625 (2017). https://doi.org/10.1038/jp.2017.25

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2017.25

Search

Advanced search

Quick links